-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TlF3s8gTGE5kifLPE4P8gM9ushu+oz6OFYBBA2JPtGwa6w8LifeiQXptJwWe5VwL JQJUKXCj7lRX7bz8/XSZbA== 0001209191-04-014145.txt : 20040303 0001209191-04-014145.hdr.sgml : 20040303 20040303212948 ACCESSION NUMBER: 0001209191-04-014145 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20040101 FILED AS OF DATE: 20040303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BERGMARK RICHARD L CENTRAL INDEX KEY: 0001282546 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14273 FILM NUMBER: 04647442 MAIL ADDRESS: STREET 1: 6316 WINDFERN ROAD CITY: HOUSTON STATE: TX ZIP: 77040 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CORE LABORATORIES N V CENTRAL INDEX KEY: 0001000229 STANDARD INDUSTRIAL CLASSIFICATION: OIL, GAS FIELD SERVICES, NBC [1389] IRS NUMBER: 000000000 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1017 BZ AMSTERDAM STREET 2: HERENGRACHT 424 CITY: THE NETHERLANDS STATE: P7 BUSINESS PHONE: 3124203191 MAIL ADDRESS: STREET 1: 6316 WINDFERN CITY: HOUSTON STATE: TX ZIP: 77040 4 1 h13221_3rlb.xml MAIN DOCUMENT DESCRIPTION X0201 4 2004-01-01 0 0001000229 CORE LABORATORIES N V CLB 0001282546 BERGMARK RICHARD L 6316 WINDFERN HOUSTON TX 77040 1 1 0 0 Executive VP and Treasurer Common Shares 2004-03-01 4 P 0 263 20.83 A 38566 I Deferred Comp. Plan Common Shares 2004-03-02 4 P 0 989 21.07 A 39555 I 401(k) Plan Common Shares 125597 D Option to Acquire Common Shares 6.00 1996-09-21 2005-09-21 Common Shares 20000 20000 D Option to Acquire Common Shares 8.375 1998-02-28 2007-02-28 Common Shares 96000 116000 D Option to Acquire Common Shares 18.375 1999-02-11 2008-02-11 Common Shares 20000 136000 D Option to Acquire Common Shares 13.0625 2000-04-07 2009-04-07 Common Shares 40000 176000 D Option to Acquire Common Shares 19.375 2001-02-23 2010-02-23 Common Shares 30000 206000 D Option to Acquire Common Shares 16.10 2002-04-03 2011-04-03 Common Shares 35000 241000 D Option to Acquire Common Shares 10.26 2002-09-26 2011-09-26 Common Shares 35000 276000 D Option to Acquire Common Shares 10.26 2002-09-26 2011-09-26 Common Shares 30000 306000 D Option to Acquire Common Shares 8.84 2004-03-13 2013-03-13 Common Shares 80000 386000 D Performance Shares 0 2004-12-31 2004-12-31 Common Shares 20000 406000 D Performance Shares 0 2005-12-31 2005-12-31 Common Shares 20000 426000 D Performance Shares 0 2004-01-01 4 A 0 20000 0 A 2006-12-31 2006-12-31 Common Shares 20000 446000 D These Common Shares were acquired pursuant to the Core Laboratories, Inc. Profit Sharing and Retirement Plan (the "401(k) Plan") or pursuant to the Core Laboratories, Inc. Deferred Compensation Plan (the "Deferred Comp Plan"), as the case may be, on various dates at various prices per share. The number of Common Shares shown in columns 4 and 5 of Table 1 is based on an allocation of the aggregate number of Common Shares acquired by the trustee under the 401(k) Plan or the Deferred Comp Plan, as the case may be, for the benefit of the plan participants who elected to make intra-plan transfers into the Common Share fund under the 401(k) Plan or the Deferred Comp Plan, as the case may be, at approximately the same time (pro rata, based on the dollar amount of each such participant's intra-plan transfer into the Common Share fund, rounding up or down to the nearest whole share). The information reported herein is based on plan statements; the amount in Column 4 is for the particular plan transaction and the amount in Column 5 is for the combined plans. This option is scheduled to become exercisable in 25% increments on each anniversary date. This option is scheduled to become exercisable in 50% increments on each anniversary date. Represents a grant of performance restricted shares which represent the right to receive our Common Shares in the future based on the performance of our Common Shares. None of these awards will vest unless our Common Shares perform better than the common stock of 50% of the companies comprising the Oil Service Sector Index (OSX) during the three-year period that began on the date of grant. If our Common Shares perform better than 75% of the companies comprising this index during such period, then all of the performance restricted shares will vest. If our common shares perform better than between 50% and 75% of the companies comprising the index, then an interpolated percentage of between 20% and 100% of the performance restricted shares will vest at the end of the three-year period. The executive will not receive dividends on or be entitled to vote the underlying Common Shares unless and until they have been issued at the end of the vesting period. 1 for 1 /s/ John D. Denson, by power of attorney 2004-03-03 EX-24 3 poa.txt POWER OF ATTORNEY POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitute and appoint each of Richard L. Bergmark, Monty L. Davis, Wanda De Bije, David M. Demshur, John D. Denson, Christine Kuhn, Dale Roberts, Kagee Walker and Kinga E. Doris, or either of them signing singly, and with full power of substitution, the undersigned's true and lawful attorney-in-fact to: (1) prepare, execute in the undersigned's name and on the undersigned' s behalf, and submit to the U.S. Securities and Exchange Commission (the "SEC") a Form ID, including amendments thereto, and any other documents necessary or appropriate to obtain codes and passwords enabling the undersigned to make electronic filings with the SEC of reports required by Section 16(a) of the Securities Exchange Act of 1934 or any rule or regulation of the SEC; (2) execute for and on behalf of the undersigned, in the undersigned's capacity as an officer and/or director of Core Laboratories N.V. (the "Company"), Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder; (3) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5, complete and execute any amendment or amendments thereto, and timely file such form with the SEC and any stock exchange or similar authority; and (4) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. IN WITNESS WHEREOF, the undersigned have caused this Power of Attorney to be executed as of this 2nd day of March, 2004. /s/ Richard L. Bergmark ------------------------------ Richard L. Bergmark /s/ Monty L. Davis ------------------------------ Monty L. Davis /s/ David M. Demshur ------------------------------ David M. Demshur /s/ John D. Denson ------------------------------ John D. Denson -----END PRIVACY-ENHANCED MESSAGE-----